Security key
528872302
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)
CUSIP: 528872302
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 121,214,904
- Total 13F value
- $711,532,085
- Share change
- -799,796
- Put/Call ratio
- 62%
- SEC-reported price per share
- $5.87
- Number of holders
- 103
- Value change
- +$117,190
- Number of buys
- 56
- Number of sells
- 48
- Shares outstanding
- 442,581,578
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
103
Top holders
10
LXRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
LEXICON PHARMACEUTICALS, INC. SEC filings
LEXICON PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 528872302
Recent filing periods:
Ownership snapshot
Top reported holders of LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Artal Group S.A.
Disclosed value leader
Artal Group S.A.
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F
Highest disclosed value: $243,430,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Artal Group S.A. has the largest disclosed position value at $243.43M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Artal Group S.A.'s linked filing trail.
Disclosed position value
Top 5
Artal Group S.A.
$243.43M
BVF INC/IL
$37.49M
FMR LLC
$28.38M
Ulys, L.L.C.
$14.78M
VANGUARD GROUP INC
$12.05M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Artal Group S.A. |
13F
Company
|
—
denominator unverified
|
$243,430,000
71,178,364 shares
|
— | 31 Dec 2020 |
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$37,493,000
10,963,000 shares
|
— | 31 Dec 2020 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$28,379,000
8,298,070 shares
|
— | 31 Dec 2020 |
| Ulys, L.L.C. |
13F
Individual
|
—
denominator unverified
|
$14,779,000
4,321,214 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$12,053,000
3,524,074 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$10,033,000
2,933,961 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
103
Shares
121,214,904
Rows available
103
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q1 2021 Across Filers
Q1 2021 holders
103
Q1 2021 holders
103
Holder diff
0
| Investor | Q1 2021 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend